Artigo Revisado por pares

Naltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials

1995; Slack Incorporated (United States); Volume: 25; Issue: 11 Linguagem: Inglês

10.3928/0048-5713-19951101-11

ISSN

1938-2456

Autores

Stephanie S. O’Malley, Robert Croop, Jill M. Wroblewski, Dominic Labriola, Joseph R. Volpicelli,

Tópico(s)

Neurotransmitter Receptor Influence on Behavior

Resumo

ADDICTION RELAPSE AND PREVENTIONNaltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials Stephanie S O'Malley, PhD, , , PhD Robert S Croop, MD, , , MD Jill M Wroblewski, MS, , , MS Dominic F Labriola, PhD, , and , PhD Joseph R Volpicelli, MD, PhD, , MD, PhD Stephanie S O'Malley, PhD , Robert S Croop, MD , Jill M Wroblewski, MS , Dominic F Labriola, PhD , and Joseph R Volpicelli, MD, PhD Psychiatric Annals, 2013;25(11):681–688Published Online:November 01, 1995https://doi.org/10.3928/0048-5713-19951101-11Cited by:56View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. O'Malley S, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence, a controlled study. Arch Gen Psychiatry. 1992; 49:881-887. Google Scholar2. Volpicelli JR, Alterman AI, O'Brien CP, Hayashida M. Naltrexone in the treatment of alcohol dependence: initial findings. In: Reid L, ed. Opioids, Bulimia, and Alcohol Abuse and Alcoholism. New York, NY: Springer-Verlag; 1990:195-214. Google Scholar3. Volpicelli JR Altormin Al, Haysuhida M, O'Brien CP Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49:876-880. Google Scholar4. Knupfer U. The risk of drunkenness (or, ebrietas resurrecta); a comparison of frequent intoxication indices and of population sub-groups as to problem risks. Br J Addict. 1984; 79:185496. Google Scholar5. Modell JO, Glaser F'B, Mountz JM, Schmaltz S~ Cyr L. Obsessive and compulsive characteristics of alcohol abuse and dependence: quantification by a newly developed questionnaire. Alcohol C/in Exp Res. 1992; 16:266-271. Google Scholar6. Anton IIF, Moak DII, Latham P. The obsessive conipulaive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Cue Exp Rca 1995; 19:92-99. Google Scholar7. Bohn MJ, Krahn DD, Staehier BA. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol din Exp Ret 1995; 19:600-606. Google Scholar8. Miller NS, Gold MS. Dissociation of "conscious desire' (craving) from and relapse in alcohol and cocaine dependence. Ann Cue Psychiatry. 1994; 6:99-106. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Patrick C and Nelson L (2013) Antisocial Personality Disorder The Wiley Handbook of Cognitive Behavioral Therapy, 10.1002/9781118528563.wbcbt53, (1263-1298), Online publication date: 10-Oct-2013. Wray J, Gass J and Tiffany S (2013) A Systematic Review of the Relationships Between Craving and Smoking Cessation, Nicotine & Tobacco Research, 10.1093/ntr/nts268, 15:7, (1167-1182), Online publication date: 1-Jul-2013. David S, Lancaster T, Stead L, Evins A and Prochaska J (2013) Opioid antagonists for smoking cessation, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003086.pub3 Stoner S and Hendershot C (2012) A randomized trial evaluating an mHealth system to monitor and enhance adherence to pharmacotherapy for alcohol use disorders, Addiction Science & Clinical Practice, 10.1186/1940-0640-7-9, 7:1, Online publication date: 1-Dec-2012. Guedes F (2012) Rastreamento e Abordagem Terapêutica de Doentes com Problemas Relacionados ao Álcool Álcool e outras drogas: diálogos sobre um mal-estar contemporâneo, 10.7476/9788575415399.0008, (151-170), . McKee S (2008) Developing human laboratory models of smoking lapse behavior for medication screening, Addiction Biology, 10.1111/j.1369-1600.2008.00135.x, 14:1, (99-107), Online publication date: 1-Jan-2009. OMalley S, Robin R, Levenson A, GreyWolf I, Chance L, Hodgkinson C, Romano D, Robinson J, Meandzija B, Stillner V, Wu R and Goldman D (2008) Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non-Natives Residing in Rural Settings: A Randomized Controlled Trial, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2008.00682.x, 32:7, (1271-1283), Online publication date: 1-Jul-2008. David S, Lancaster T, Stead L, Evins A, Cahill K and David S (2006) Opioid antagonists for smoking cessation Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003086.pub2 Roozen H, de Waart R, van der Windt D, van den Brink W, de Jong C and Kerkhof A (2006) A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence, European Neuropsychopharmacology, 10.1016/j.euroneuro.2005.11.001, 16:5, (311-323), Online publication date: 1-Jul-2006. Johnson B, Koob G, Schuckit M, Mason B and Ait-Daoud N (2006) Understanding and Treating Alcohol Dependence, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2005.00066.x, 30:3, (567-584), Online publication date: 1-Mar-2006. Luty J (2018) What works in alcohol use disorders?, Advances in Psychiatric Treatment, 10.1192/apt.12.1.13, 12:1, (13-22), Online publication date: 1-Jan-2006. Kreek M (2005) Impact of bidirectional translational research on treatment of addiction, Clinical Neuroscience Research, 10.1016/j.cnr.2005.08.008, 5:2-4, (123-139), Online publication date: 1-Nov-2005. Thomas S and Deas D (2005) The A-OCDS predicts both craving and alcohol cue reactivity in adolescent alcoholics, Addictive Behaviors, 10.1016/j.addbeh.2005.07.018, 30:9, (1638-1648), Online publication date: 1-Oct-2005. Drobes D, Anton R, Thomas S and Voronin K (2004) Effects of Naltrexone and Nalmefene on Subjective Response to Alcohol Among Non-Treatment-Seeking Alcoholics and Social Drinkers, Alcoholism: Clinical & Experimental Research, 10.1097/01.ALC.0000139704.88862.01, 28:9, (1362-1370), Online publication date: 1-Sep-2004. TUCKER T, RITTER A, MAHER C and JACKSON H (2009) Naltrexone maintenance for heroin dependence: uptake, attrition and retention, Drug and Alcohol Review, 10.1080/09595230412331289464, 23:3, (299-309), Online publication date: 1-Sep-2004. Rohsenow D (2004) What Place Does Naltrexone Have in the Treatment of Alcoholism?, CNS Drugs, 10.2165/00023210-200418090-00001, 18:9, (547-560), . Naegle M (2003) A world view of nurses and midwives responding to alcohol, tobacco and other drug issues, Drugs and Alcohol Today, 10.1108/17459265200300037, 3:4, (31-39), Online publication date: 1-Dec-2003. McGovern M and Carroll K (2003) Evidence-based practices for substance use disorders, Psychiatric Clinics of North America, 10.1016/S0193-953X(03)00073-X, 26:4, (991-1010), Online publication date: 1-Dec-2003. Balldin J, Berglund M, Borg S, M??nsson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson L, Stolt G and Willander A (2003) A 6-Month Controlled Naltrexone Study: Combined Effect With Cognitive Behavioral Therapy in Outpatient Treatment of Alcohol Dependence, Alcoholism: Clinical & Experimental Research, 10.1097/01.ALC.0000075548.83053.A9, 27:7, (1142-1149), Online publication date: 1-Jul-2003. Egli M (2003) Peptides: their role in excess alcohol drinking and their promise as a therapeutic tool, Physiology & Behavior, 10.1016/S0031-9384(03)00108-2, 79:1, (89-93), Online publication date: 1-Jun-2003. Drobes D, Anton R, Thomas S and Voronin K (2002) A Clinical Laboratory Paradigm for Evaluating Medication Effects on Alcohol Consumption: Naltrexone and Nalmefene, Neuropsychopharmacology, 10.1038/sj.npp.1300101, 28:4, (755-764), Online publication date: 1-Apr-2003. Ahmadi J, Ashkani H, Ahmadi M and Ahmadi N (2003) Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone, Journal of Substance Abuse Treatment, 10.1016/S0740-5472(03)00027-8, 24:3, (251-255), Online publication date: 1-Apr-2003. Gastpar M, Bonnet U, Böning J, Mann K, Schmidt L, Soyka M, Wetterling T, Kielstein V, Labriola D and Croop R (2002) Lack of Efficacy of Naltrexone in the Prevention of Alcohol Relapse: Results From a German Multicenter Study, Journal of Clinical Psychopharmacology, 10.1097/00004714-200212000-00009, 22:6, (592-598), Online publication date: 1-Dec-2002. Barnes H (2023) Article Commentary: Creating Meaning and Value in Substance Abuse Education, Substance Abuse, 10.1080/08897070209511492, 23:4, (203-209), Online publication date: 1-Dec-2002. Kreek M, LaForge K and Butelman E (2002) Pharmacotherapy of addictions, Nature Reviews Drug Discovery, 10.1038/nrd897, 1:9, (710-726), Online publication date: 1-Sep-2002. Latt N, Jurd S, Houseman J and Wutzke S (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting, Medical Journal of Australia, 10.5694/j.1326-5377.2002.tb04550.x, 176:11, (530-534), Online publication date: 1-Jun-2002. Feeney G, Connor J, Young R, McPherson A and Tucker J (2002) Improved psychosocial function following low-intensity, 12-week outpatient alcohol rehabilitation programme: preliminary report, Internal Medicine Journal, 10.1046/j.1445-5994.2002.00194.x, 32:4, (197-198), Online publication date: 1-Apr-2002. Krystal J, Cramer J, Krol W, Kirk G and Rosenheck R (2001) Naltrexone in the Treatment of Alcohol Dependence, New England Journal of Medicine, 10.1056/NEJMoa011127, 345:24, (1734-1739), Online publication date: 13-Dec-2001. Monti P, Rohsenow D, Swift R, Gulliver S, Colby S, Mueller T, Brown R, Gordon A, Abrams D, Niaura R and Asher M (2001) Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1-Year Outcomes, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2001.tb02170.x, 25:11, (1634-1647), Online publication date: 1-Nov-2001. Monti P, Rohsenow D, Swift R, Gulliver S, Colby S, Mueller T, Brown R, Gordon A, Abrams D, Niaura R and Asher M (2001) Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1-Year Outcomes, Alcoholism: Clinical and Experimental Research, 10.1097/00000374-200111000-00011, 25:11, (1634-1647), Online publication date: 1-Nov-2001. Kranzler H and Kirk J (2001) Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2001.tb02356.x, 25:9, (1335-1341), Online publication date: 1-Sep-2001. Littrell J (2001) What Neurobiology has to Say About Why People Abuse Alcohol and Other Drugs, Journal of Social Work Practice in the Addictions, 10.1300/J160v01n03_03, 1:3, (23-40), Online publication date: 1-Aug-2001. David S, Lancaster T, Stead L and David S (2001) Opioid antagonists for smoking cessation Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003086 Heinälä P, Alho H, Kiianmaa K, Lönnqvist J, Kuoppasalmi K and Sinclair J (2001) Targeted Use of Naltrexone Without Prior Detoxification in the Treatment of Alcohol Dependence: A Factorial Double-Blind, Placebo-Controlled Trial, Journal of Clinical Psychopharmacology, 10.1097/00004714-200106000-00006, 21:3, (287-292), Online publication date: 1-Jun-2001. LEE A, TAN S, LIM D, WINSLOW R, WONG K, ALLEN J, HALL W and PARKER G (2009) Naltrexone in the treatment of male alcoholics-an effectiveness study in Singapore, Drug and Alcohol Review, 10.1080/09595230124192, 20:2, (193-199), Online publication date: 1-Jun-2001. Weinrieb R, Van Horn D, Mclellan A, Alterman A, Calarco J, O'Brien C and Lucey M (2001) Alcoholism Treatment After Liver Transplantation: Lessons Learned From a Clinical Trial That Failed, Psychosomatics, 10.1176/appi.psy.42.2.110, 42:2, (110-116), Online publication date: 1-Mar-2001. Solé A (2001) Evolución clínica del alcoholismo tratado con naltrexona. Efectividad y seguridad en una muestra de 198 pacientes, Medicina Clínica, 10.1016/S0025-7753(01)71894-5, 116:14, (526-532), . Rohsenow D, Monti P, Hutchison K, Swift R, Colby S and Kaplan G (2000) Naltrexone's effects on reactivity to alcohol cues among alcoholic men., Journal of Abnormal Psychology, 10.1037/0021-843X.109.4.738, 109:4, (738-742) Rohsenow D, Colby S, Monti P, Swift R, Martin R, Mueller T, Gordon A and Eaton C (2000) Predictors of Compliance with Naltrexone Among Alcoholics, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2000.tb04573.x, 24:10, (1542-1549), Online publication date: 1-Oct-2000. Fawcett J, Kravitz H, McGuire M, Easton M, Ross J, Pisani V, Fogg L, Clark D, Whitney M, Kravitz G, Javaid J and Teas G (2000) Pharmacological Treatments for Alcoholism: Revisiting Lithium and Considering Buspirone, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.2000.tb02038.x, 24:5, (666-674), Online publication date: 1-May-2000. Fawcett J, Kravitz H, McGuire M, Easton M, Ross J, Pisani V, Fogg L, Clark D, Whitney M, Kravitz G, Javaid J and Teas G (2000) Pharmacological Treatments for Alcoholism: Revisiting Lithium and Considering Buspirone, Alcoholism: Clinical and Experimental Research, 10.1097/00000374-200005000-00011, 24:5, (666-674), Online publication date: 1-May-2000. O'Connor P (2000) Primary Care Setting Handbook of Alcoholism, 10.1201/9781420036961.ch14, (165-172), Online publication date: 24-Mar-2000. Kurz M, Hinterhuber H, Zernig G, Wolfgang Fleischhacker W and Saria A (2000) Pharmacotherapy Handbook of Alcoholism, 10.1201/9781420036961.ch10, (121-127), Online publication date: 24-Mar-2000. Anton R, Moak D, Waid L, Latham P, Malcolm R and Dias J (1999) Naltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial, American Journal of Psychiatry, 10.1176/ajp.156.11.1758, 156:11, (1758-1764), Online publication date: 1-Nov-1999. Monti P, Rohsenow D, Hutchison K, Swift R, Mueller T, Colby S, Brown R, Gulliver S, Gordon A and Abrams D (1999) Naltrexone's Effect on Cue-Elicited Craving Among Alcoholics in Treatment, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.1999.tb04361.x, 23:8, (1386-1394), Online publication date: 1-Aug-1999. Kranzler H, Amin H, Modesto-Lowe V and Oncken C (1999) PHARMACOLOGIC TREATMENTS FOR DRUG AND ALCOHOL DEPENDENCE, Psychiatric Clinics of North America, 10.1016/S0193-953X(05)70084-8, 22:2, (401-423), Online publication date: 1-Jun-1999. Anton R and Drobes D (1998) Clinical Measurement of Craving in Addiction, Psychiatric Annals, 10.3928/0048-5713-19981001-06, 28:10, (553-560), Online publication date: 1-Oct-1998. Boyle A, Stewart R, Macenski M, Spiga R, Johnson B and Meisch R (1998) Effects of Acute and Chronic Doses of Naltrexone on Ethanol Self-Administration in Rhesus Monkeys, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.1998.tb03661.x, 22:2, (359-366), Online publication date: 1-Apr-1998. O'Connor P and Schottenfeld R (1998) Patients with Alcohol Problems, New England Journal of Medicine, 10.1056/NEJM199802263380907, 338:9, (592-602), Online publication date: 26-Feb-1998. O'Connor P, Farren C, Rounsaville B and O'Malley S (1997) A Preliminary Investigation of the Management of Alcohol Dependence With Naltrexone by Primary Care Providers, The American Journal of Medicine, 10.1016/S0002-9343(97)00271-4, 103:6, (477-482), Online publication date: 1-Dec-1997. CHICK J (2006) Pitfalls and possibilities in evaluating pharmacotherapies for alcohol dependence, Addiction, 10.1111/j.1360-0443.1997.tb02970.x, 92:8, (953-956), Online publication date: 1-Aug-1997. Saitz R and O'Malley S (1997) PHARMACOTHERAPIES FOR ALCOHOL ABUSE, Medical Clinics of North America, 10.1016/S0025-7125(05)70554-X, 81:4, (881-907), Online publication date: 1-Jul-1997. Chick J (1997) Alcohol and the brain, Current Opinion in Psychiatry, 10.1097/00001504-199705000-00005, 10:3, (205-210), Online publication date: 1-May-1997. Weinrieb, MD R and O'Brien, MD, PhD C (1997) NALTREXONE IN THE TREATMENT OF ALCOHOLISM, Annual Review of Medicine, 10.1146/annurev.med.48.1.477, 48:1, (477-487), Online publication date: 1-Feb-1997. Ahmed I and Takeshita J (1997) Biopsychosocial Approaches to Mental Disorders in the Elderly Biopsychosocial Approaches in Primary Care, 10.1007/978-1-4615-5957-3_8, (93-117), . Litten R, Allen J and Fertig J (1996) Pharmacotherapies for Alcohol Problems: A Review of Research with Focus on Developments since 1991, Alcoholism: Clinical and Experimental Research, 10.1111/j.1530-0277.1996.tb05264.x, 20:5, (859-876), Online publication date: 1-Aug-1996. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 8.4 MB Published online11/01/95

Referência(s)
Altmetric
PlumX